Which indirect cholinomimetic agent has a longer duration than neostigmine and is used in the treatment of myasthenia gravis?

Which indirect cholinomimetic agent has a longer duration than neostigmine and is used in the treatment of myasthenia gravis?

• A. Pyridostigmine
• B. Neostigmine
• C. Physostigmine
• D. Organophosphate

Answer: (A)

Indirect acting cholinomimetic drugs work by inhibiting acetylcholinesterase, which increases acetylcholine at the neuromuscular junction to improve transmission in conditions like myasthenia gravis, where receptor availability is reduced. Among these agents, pyridostigmine provides a longer duration of action than neostigmine, making it more suitable for ongoing management of MG. Its effect lasts several hours, offering more sustained relief from symptoms with easier dosing. Physostigmine, while also an acetylcholinesterase inhibitor, is a tertiary amine that crosses the blood–brain barrier, leading to central effects and typically a shorter peripheral duration, and it’s not the standard choice for MG. Organophosphates irreversibly inhibit acetylcholinesterase and are toxic, not used for treating MG.

Indirect acting cholinomimetic drugs work by inhibiting acetylcholinesterase, which increases acetylcholine at the neuromuscular junction to improve transmission in conditions like myasthenia gravis, where receptor availability is reduced. Among these agents, pyridostigmine provides a longer duration of action than neostigmine, making it more suitable for ongoing management of MG. Its effect lasts several hours, offering more sustained relief from symptoms with easier dosing.

Physostigmine, while also an acetylcholinesterase inhibitor, is a tertiary amine that crosses the blood–brain barrier, leading to central effects and typically a shorter peripheral duration, and it’s not the standard choice for MG. Organophosphates irreversibly inhibit acetylcholinesterase and are toxic, not used for treating MG.